KMA to discuss possibility of reserving the submission of list of prescription medicines.

Published: 2001-09-04 06:56:00

Updated: 2001-09-04 06:56:00

The Korea Medical Association (KMA) will hold a board of medical affairs directors' meeting today (30th) to discuss the selection for the prescription medicine list and the Enforcement Ordinance & regulations of the Pharmaceutical Affairs Law.

The meeting is attracting great attention because...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK